Track this trial free. DataLookout checks ClinicalTrials.gov daily and emails you which fields changed on NCT05512754 (status, enrollment, completion dates, endpoints, sites) when this record is updated. Free accounts track up to 5 trials.

Track this trial

Impact of Anti-inflammatory Medications in Patients With Elevated Serum Prostate-specific Antigen

StatusRecruiting
PhasePhase 4
Started
View on ClinicalTrials.gov ↗

Record History

See every version on ClinicalTrials.gov ↗

  1. Primary and study completion dates: Dec 1, 2025 to Dec 31, 2027v9
  2. Primary and study completion dates: Aug 1, 2025 to Dec 1, 2025
    • Site contacts updated at 1 of 3 sites
    v8
  3. Study sites: 1 to 3v7
  4. Primary and study completion dates: Jul 31, 2024 to Aug 1, 2025v6
  5. Eligibility criteria expanded, about 11 wordsv5
Show 3 earlier versionsHide 3 earlier versions
  1. Re-verified, no change to tracked fieldsv4
  2. Trial status: Active, Not Recruiting to Recruiting
    • Site details revised
    v3
  3. Secondary endpoints: details revised at 1 of 1 entry
    • Study title shortened, about 2 words
    v2
  1. Study First Submitted
  • Stopped: an ongoing trial was terminated, suspended or withdrawn.
  • Notable: the trial’s plan changed such as a big move in its timeline or size, a new primary endpoint, sponsor or phase, or recruiting opened or resumed.
  • Minor: routine progress and housekeeping, such as sites added or enrollment closed.
The purpose of this study is to assess the impact of ibuprofen in men with elevated serum PSA.
Trial Details
NCT Number NCT05512754
Lead Sponsor University of Chicago
Conditions
(from sponsor)		 Elevated Serum PSA
Enrollment 200 participants
Start Date
Primary Completion (estimated)
Study Completion (estimated)
Updated on ClinicalTrials.gov